Kiora Pharmaceuticals Eulerpool naujienos

Kiora Pharmaceuticals Eulerpool News

Kiora Pharmaceuticals akcijų naujienos

Kiora Pharmaceuticals stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Kiora Pharmaceuticals naujienas mes pateikiame čia.

• rugsėjo 25 d. ·

  Yahoo
  Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences
• rugpjūčio 12 d. ·

  Thefly.com
  Kiora Pharmaceuticals target ajusted to $54 from $6 at Ladenburg
• rugpjūčio 10 d. ·

  TipRanks
  Buy Rating on Kiora Pharmaceuticals: Strong Financials and Promising KIO-301 Progress
• rugpjūčio 9 d. ·

  Yahoo
  Kiora Pharmaceuticals Reports Second Quarter Results; Retinal Disease Drug Development Pipeline Advancing Toward Two Phase 2 Studies
• rugpjūčio 9 d. ·

  Seeking Alpha
  Kiora Pharmaceuticals GAAP EPS of -$0.53 beats by $0.33
• rugpjūčio 9 d. ·

  InvestorPlace
  KPRX Stock Earnings: Kiora Pharmaceuticals Beats EPS for Q2 2024
• rugpjūčio 6 d. ·

  Yahoo
  Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences
• liepos 30 d. ·

  Yahoo
  Kiora Pharmaceuticals Receives European Orphan Medicinal Product Designation for KIO-301 for the Treatment of Inherited Retinal Dystrophies
• liepos 22 d. ·

  TipRanks
  Buy Rating Affirmed for Kiora Pharmaceuticals Amid Strategic Enhancements and Clinical Progress
• liepos 10 d. ·

  Yahoo
  Kiora Pharmaceuticals to Participate in Jones Healthcare Seaside Summit 2024; Kiora Invites Investors to Submit Questions Following the Conference Presentation